RE: safetyman5 Nov 2020 17:05
Troajan
There are many strains of Coronavirus including the common cold mate, and whilst they are trying to develop vaccines all over the world, which will take time, there is also a therapeutic treatment that is now starting a stage 3 trial, that at stage 2 in uk hospitals in the first wave, had a 79% success rate in stopping patients who were given it, from ending up in intensive care, it’s called SNG001 made by a company called Synairgen and they have just raised £80 million from institutions and at the same time £7 million from private investors, to run the stage 3 trial and to produce millions of doses, so, all is not lost mate, science will prevail.